PrrAB is a Selective Therapeutic Target and Regulator of Respiration in Mycobacterium tuberculosis
ACS Infectious Diseases · 2025
DOI: 10.1021/acsinfecdis.5c00563 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, 2025. Verfasst von Yannik A Haller und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Arizona State University, Tempe, Arizona 85287, United States. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Bacterial Proteins, Antitubercular Agents. Die Arbeit nennt 75 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Arizona State University, Tempe, Arizona 85287, United States.
- Biodesign Institute Center for Bioelectronics and Biosensors, Arizona State University, Tempe, Arizona 85287, United States.
ORCID-Profile: Yannik A Haller, Shelley E Haydel
Zitieren
APA
Haller, Y. A., Aguilera Olvera, R., Yakimovich, L., Anderson, L., Heiligenstein, P., & Haydel, S. E. (2025). PrrAB is a Selective Therapeutic Target and Regulator of Respiration in Mycobacterium tuberculosis. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.5c00563
Vancouver
Haller YA, Aguilera Olvera R, Yakimovich L, Anderson L, Heiligenstein P, Haydel SE. PrrAB is a Selective Therapeutic Target and Regulator of Respiration in Mycobacterium tuberculosis. ACS Infectious Diseases. 2025. doi:10.1021/acsinfecdis.5c00563
BibTeX
@article{Haller2025,
author = {Haller, Yannik A and Aguilera Olvera, Rodrigo and Yakimovich, Lexi and Anderson, Laura and Heiligenstein, Piper and Haydel, Shelley E},
title = {PrrAB is a Selective Therapeutic Target and Regulator of Respiration in Mycobacterium tuberculosis},
journal = {ACS Infectious Diseases},
year = {2025},
doi = {10.1021/acsinfecdis.5c00563}
}
EUVIMED